Clinical Trial

A Clinical Study to Evaluate the Efficacy and Safety of Bempedoic Acid

Name: A Clinical Study to Evaluate the Efficacy and Safety of Bempedoic Acid — clinical trial record (NCT07623915)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

This trial is a multicenter randomized, double-blind, placebo-controlled phase III study to evaluate the efficacy and safety of Bempedoic Acid Tablets in patients with hyperlipidemia not adequately controlled by Statins.

Trial Details

NCT Number	NCT07623915
Lead Sponsor	CSPC Ouyi Pharmaceutical Co., Ltd.
Conditions	Primary Hyperlipidemia
Enrollment	222 participants
Start Date	2026-06-12
Primary Completion	2027-06-30 (estimated)
Study Completion	2027-08-28 (estimated)
Updated on ClinicalTrials.gov	2026-06-03